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The phenomenon of epithelial-mesenchymal transition
(EMT) has been proposed as a relevant event during carci-
noma progression. Tumor EMT drives the phenotypic
conversion of polarized, epithelial tumor cells into highly
motile, mesenchymal-like cells, and promotes tumor disse-
mination and metastasis and the acquisition of tumor
resistance to various therapies. In order to investigate the
potential role of EMT in the modulation of the tumor
microenvironment as well as to identify soluble factors
that could initiate and/or maintain tumor EMT, isogenic
tumor cell pairs with epithelial vs. mesenchymal-like fea-
tures were generated via modulation of the expression of
an EMT driver, the T-box transcription factor Brachyury.
A characterization of the pattern of soluble factors
secreted by each cell type showed that acquisition of a
mesenchymal-like phenotype by epithelial tumor cells was
associated with secretion of multiple cytokines and che-
mokines and, in particular, markedly enhanced the expres-
sion of the interleukin-8 (IL-8)/IL-8R axis. Interference
with IL-8 signaling via IL-8 neutralization or blockade of
IL-8 receptors was able to revert the invasive, mesenchy-
mal phenotype of Brachyury-high tumor cells towards a
non-invasive, epithelial one, therefore indicating that upre-
gulation of the IL-8/IL-8R axis is critical for the mainte-
nance of tumor EMT. The ability of IL-8 to induce EMT
was also demonstrated on a panel of epithelial cancer cell
lines that showed increased expression of mesenchmal
markers, cell migration and invasion in response to
recombinant IL-8. The correlation between Brachyury,
tumor EMT and IL-8 expression was also investigated
with various lung and colon cancer cell lines with acquired
resistance to EGFR inhibition. These resistant cells exhib-
ited changes characteristic of EMT, had high levels of
brachyury and other EMT markers expression, and
secreted significantly higher level of IL-8 compared to
parental cells. Collectively, our results emphasize the role
of the IL-8/IL-8R axis in the modulation of human tumor
EMT and form the rationale for further investigations on
the modulation of IL-8 signaling in the tumor microenvir-
onment as an approach against carcinoma progression.
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